1-6 of 6
David Loegering
Close
Sort by
Journal Articles

Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas

Clinical Trials & Observations
Thomas E. Witzig, Hui Tang, Ivana N. M. Micallef, Stephen M. Ansell, Brian K. Link, David J. Inwards, Luis F. Porrata, Patrick B. Johnston, Joseph P. Colgan, Svetomir N. Markovic, Grzegorz S. Nowakowski, Carrie A. Thompson, Cristine Allmer, Matthew J. Maurer, Mamta Gupta, George Weiner, Ray Hohl, Paul J. Kurtin, Husheng Ding, David Loegering, Paula Schneider, Kevin Peterson, Thomas M. Habermann, Scott H. Kaufmann
Journal: Blood
Blood (2011) 118 (18): 4882–4889.
https://doi.org/10.1182/blood-2011-02-334904
Published: 2011
Journal Articles

Adaphostin-induced oxidative stress overcomes BCR/ABL mutation-dependent and -independent imatinib resistance

Joya Chandra, Jeannette Tracy, David Loegering, Karen Flatten, Srdan Verstovsek, Miloslav Beran, Mercedes Gorre, Zeev Estrov, Nicholas Donato, Moshe Talpaz, Charles Sawyers, Kapil Bhalla, Judith Karp, Edward Sausville, Scott H. Kaufmann
Journal: Blood
Blood (2006) 107 (6): 2501–2506.
https://doi.org/10.1182/blood-2005-07-2966
Published: 2006
Journal Articles

JAK2 (V617F) Mutation Status and Neutrophil Apoptotic Resistance in Myelofibrosis with Myeloid Metaplasia (MMM): Correlation and Potential Identification through Phosphorylation Status of STAT3.

Ruben A. Mesa, MD, Ayalew Tefferi, MD, Heather Powell, MS, Terra Lasho, BS, David Loegering, BS, Scott H. Kaufmann, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 3503.
https://doi.org/10.1182/blood.V106.11.3503.3503
Published: 2005
Journal Articles

Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine

Ruben A. Mesa, David Loegering, Heather L. Powell, Karen Flatten, Sonnet J. H. Arlander, Nga T. Dai, Michael P. Heldebrant, Benjamin T. Vroman, B. Douglas Smith, Judith E. Karp, Cynthia J. Ten Eyck, Charles Erlichman, Scott H. Kaufmann, Larry M. Karnitz
Journal: Blood
Blood (2005) 106 (1): 318–327.
https://doi.org/10.1182/blood-2004-09-3523
Published: 2005
Journal Articles

Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells

Joya Chandra, Jennifer Hackbarth, Son Le, David Loegering, Nancy Bone, Laura M. Bruzek, Ven L. Narayanan, Alex A. Adjei, Neil E. Kay, Ayalew Tefferi, Judith E. Karp, Edward A. Sausville, Scott H. Kaufmann
Journal: Blood
Blood (2003) 102 (13): 4512–4519.
https://doi.org/10.1182/blood-2003-02-0562
Published: 2003
Journal Articles

Regulation and Processing of a Precursor Form of Eosinophil Granule Major Basic Protein (ProMBP) in Differentiating Eosinophils

Pamela Popken-Harris, James Checkel, David Loegering, Benjamin Madden, Margaret Springett, Gail Kephart, Gerald J. Gleich
Journal: Blood
Blood (1998) 92 (2): 623–631.
https://doi.org/10.1182/blood.V92.2.623
Published: 1998